Clinical Trials Logo

Clinical Trial Summary

Bicuspid Aortic Valve (BAV) is the most common congenital heart disease affecting 1-2% of the population. The aortic dilation and aortic valve degeneration are common complications in patients with BAV. Statins have shown a reduction in the expression of metalloproteinases of the extracellular matrix observed in aortic aneurisms. Several retrospective studies have suggested the benefit of the statins to reduce aortic dilation in patients with BAV. Moreover, although statins did not show to be useful in the progression of aortic stenosis, different studies have suggested a higher profit when the valve affection is not severe. The objective of this study is to determine whether atorvastatin is effective at reducing the progression of aortic dilation in patients with BAV.


Clinical Trial Description

BICATOR is a multicentre (8 centres), randomised, double-blind and placebo-controlled clinical trial aimed at evaluating the effect of atorvastatin in reducing progression of aortic dilation in patients with BAV. The primary outcome is to determine whether atorvastatin is effective in reducing aortic dilation in BAV and secondary outcome is to define if atorvastatin treatment slows the progression of aortic valve degeneration (valve calcification) in a 3 year follow-up period. 220 patients will be included (110 atorvastatin - 110 placebo). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02679261
Study type Interventional
Source Hospital Universitari Vall d'Hebron Research Institute
Contact
Status Completed
Phase Phase 3
Start date June 2016
Completion date February 2021

See also
  Status Clinical Trial Phase
Recruiting NCT01390181 - The Effect of Losartan in Bicuspid Aortic Valve Patients N/A
Enrolling by invitation NCT06212050 - Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
Active, not recruiting NCT03635424 - Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study N/A
Recruiting NCT06153407 - Genetic Test Based Risk Prediction of Early Calcific Aortic Valve Disease in Patients With Bicuspid Aortic Valve
Active, not recruiting NCT03474159 - Evaluation of Aortic Stiffness as a Prognostic Indicator of Aortic Dilatation in Patients With Bicuspid Aortic Valve by Multimodal Imaging N/A
Not yet recruiting NCT06375590 - NavIIcusp: Bicuspid Aortic Valve Stenosis With Navitor Platform International Experience
Recruiting NCT05739253 - Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
Completed NCT01823432 - Genetic Risks for Bicuspid Aortic Valve Disease
Completed NCT01920815 - Bicuspid Valve Aortopathy Feasibility Study
Recruiting NCT04817735 - The CASPER Registry N/A
Recruiting NCT02899624 - Whole Exome Sequencing in Bicuspid Aortic Valve Patients N/A
Recruiting NCT05708118 - Progression of Ascending Aorta Diameters in Bicuspid Aortic Valve After Transcatheter or Surgical Replacement.
Recruiting NCT03495050 - BIVOLUTX: Bicuspid Aortic Stenosis With Evolut Platform International Experience.
Completed NCT01760668 - Aortopathy in Persons With Bicuspid Aortic Valve, Turner and Marfan Syndrome N/A
Not yet recruiting NCT05711693 - Measurement of Heart-carotid Pulse Wave Velocity (hcPWV) by Laser Doppler Vibrometry (LDV) N/A
Completed NCT05836363 - Fate at Long-term of Mild to Moderate Bicuspid Aortic Valve Disease Left Untreated at the Time of Supracoronary Ascending Aorta Replacement
Completed NCT02283970 - Investigation of Patients With BAV Requiring Valve and/or Aortic Repair (GISSI Outliers VAR)
Active, not recruiting NCT01026571 - Identification of Genetic Causes of Bicuspid Aortic Valve Disease
Completed NCT00412386 - Abnormal 3-D MRI Flow Patterns in Adolescents Patients With Bicuspid Aortic Valve N/A
Recruiting NCT03440697 - Pathogenetic Basis of Aortopathy and Aortic Valve Disease